Analyses of DNA methylation and histone methylation changes in human malignancies
| Project/Area Number |
20590325
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Pathological medical chemistry
|
|---|
| Research Institution | Aichi Cancer Center Research Institute |
|---|
Principal Investigator |
KONDO Yutaka Aichi Cancer Center Research Institute, 分子腫瘍学部, 室長 (00419897)
|
|---|
| Research Collaborator |
安 炳九 愛知県がんセンター(研究所), 分子腫瘍学部, リサーチレジデント
新城 恵子 愛知県がんセンター(研究所), 分子腫瘍学部, 連携大学院生
|
|---|
| Project Period (FY) |
2008 – 2009
|
| Project Status |
Completed (Fiscal Year 2009)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Keywords | 分子腫瘍学 / エピジェネティクス / 遺伝子制御機構 / ヒストンメチル化 / DNAメチル化 / 発がん / がん抑制遺伝子 / ヒストン修飾 / マイクロアレイ / 悪性胸膜中皮腫 |
|---|
| Research Abstract |
In the current study, to clarify the contribution of epigenetic abnormalities to the human tumorigenesis, we conducted high-throughput analysis of DNA methylation, lysine 27 trimethylation and genetic alterations in human malignancies. Using malignant mesothelioma as a model, we demonstrated a characteristic epigenetic profile of human mesothelioma and uncover multiple distinct epigenetic abnormalities that lead to the silencing of tumor-suppressor genes in mesothelioma and could serve as diagnostic or prognostic targets.
|
Report
(3 results)
Research Products
(43 results)
-
-
-
-
[Journal Article] Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling.2009
Author(s)
Yuki K, Natsume A, Yokoyama H, Kondo Y, (他6名、4番目), Ohno M, Kato T, Chansakul P, Ito M, Kim S, Wakabayashi T.
-
Journal Title
Cancer Lett. Vol.284,No.1
Pages: 71-9
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
